This product is not sold in us and is 510(k) exempt.Title: factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study source: clinical colorectal cancer, vol.20, no.2, e82-95.If information is provided in the future, a supplemental report will be issued.
|
According to the literature, a retrospective study identified incidence and risk factors associated with local tumor control and complications following percutaneous thermal ablation of colorectal cancer liver metastases.Between (b)(6) 2003 and (b)(6) 2017, 286 patients with 378 thermal ablation procedures were included in this study.Of these, cool tip rf electrodes were used in 110 of 213 procedures.Emprint mwa was used in 39 of 165 procedures.415 tumors were treated in 378 procedures.Post procedural major complications included: intrahepatic biloma (6), biliary stenosis (3) hyperbilirubinemia (3), bilioenteric/biliogastric fistula (2), extrahepatic biloma with infection and bile leak (1), arterioportal fistula (2), hepatic pseudoaneurysm and hematoma (3), retroperitoneal hematoma (1), bleeding (1), pulmonary embolism (2), pneumothorax and pleural effusion (2), svc thrombosis syndrome (1), hemothorax (1), pleural effusion (1), diaphragm injury (1), pneumothorax with pneumomediastinum, pneumoperitoneum and subcutaneous emphysema (1) for a total of 33 major complications.Post procedural minor complications included: biloma (7) hyperbilirubinemia/transaminase toxity (1) intrahepatic hematoma (6) portal vein injury/thrombosis (2) arteriovenous fistula (1) perihepatic bleeding during ablation (1) pneumothorax (17) pleural effusion (4) asthma exacerbation (1) non cardiac chest pain (5), post ablation syndrome (3).It is unknown whether the complications were related or associated with our devices.
|